Table 1

Characteristics of study subjects

SubjectAge/sexFEV1 (% predicted)Methacholine PC20 (mg/ml)Atopy
*Variation in FEV1 of >20% and >20% improvement after salbutamol.
141/M73.54.24Yes
235/M107.13.22Yes
327/F103.14.70Yes
426/F71.00.23Yes
5*25/F95.8>16No
6*29/M99.5>16No
738/M85.72.11Yes
833/M91.70.93Yes
942/M103.03.12Yes
1028/M81.52.46Yes